文献速递冠心病

远程缺血适应在ST段抬高型心肌梗死中的注册随机试验

Remote ischaemic conditioning in ST elevation myocardial infarction: a registry-based randomised trial.
PubMed 文献 · Heart · 2021-08-20

该注册随机试验纳入252例接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者,对比远程缺血适应与标准治疗。结果显示远程缺血适应未改善心肌灌注、未缩小心肌梗死面积、未改变左心室功能,1年内临床复合终点无差异。

要点

  • 远程缺血适应未改善STEMI患者直接PCI后的心肌灌注。
  • 远程缺血适应未缩小心肌梗死面积或改变左心室功能。
  • 1年临床复合终点在远程缺血适应与标准治疗间无差异。

核心结论

  • 在当代STEMI接受PPCI的患者中,辅助远程缺血适应未改善心肌灌注、未缩小心肌梗死面积、未改变左心室功能,1年内临床结局无差异。

研究设计与样本

  • 注册随机研究纳入252例STEMI患者,随机分配至远程缺血适应组或标准治疗组。
  • 远程缺血适应方案为血压袖带充气至200 mmHg持续5分钟缺血后复灌5分钟,共4个循环。

主要发现

  • 远程缺血适应组与标准治疗组Sum ST段偏差缓解≥50%比例相似(65.2% vs 55.7%,p=0.269)。
  • 3天心脏磁共振亚组(n=88)中,心肌梗死面积中位数无差异(14.9% vs 16.1%,p=0.980)。
  • 3天心脏磁共振亚组中,左心室舒张末期容积指数、收缩末期容积指数及射血分数均无差异(p分别为0.630、0.551、0.554)。
  • 90天心脏磁共振结果与3天结果相似。
  • 1年死亡、充血性心力衰竭、心源性休克和再发心肌梗死复合终点无差异(21.7% vs 13.3%,p=0.110)。

临床怎么用

  • 不推荐将远程缺血适应作为STEMI直接PCI的常规辅助治疗以改善心肌灌注或临床结局。

局限性

  • 心脏磁共振亚组样本量较小(n=88)。
  • 临床复合终点事件数较少,统计效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Remote ischaemic conditioning (RIC) has been tested as a possible strategy for mitigating reperfusion injury in ST elevation myocardial infarction (STEMI) with primary percutaneous coronary intervention (PPCI). However, surrogate outcomes have shown inconsistent effects with lack of clinical correlation. METHODS: We performed a registry-based randomised study of patients with STEMI allocated to RIC (4 cycles of blood pressure cuff inflation to 200 mm Hg for 5 min of ischaemia followed by 5 min of reperfusion) or standard of care (SOC) during PPCI. We examined the associations of RIC on core laboratory measurements of myocardial perfusion, infarct size (IS), left ventricular (LV) performance and clinical outcomes. RESULTS: A total of 252 patients were enrolled. The median age was 61 (IQR: 55-70) years and 72.8% were male. Sum ST segment deviation resolution ≥50% was similar between RIC and SOC (65.2% vs 55.7%, p=0.269). In those with 3-day cardiovascular MRI (n=88), no difference in median (25th, 75th percentiles) IS (14.9% (4.5%, 23.1%) vs 16.1% (3.3%, 22.0%), p=0.980), LV dimensions (LV end-diastolic volume index: 78.7 (71.1, 91.2) mL/m2 vs 79.9 (71.2, 88.8) mL/m2, p=0.630; LV end-systolic volume index: 48.8 (35.7, 51.4) mL/m2 vs 37.9 (31.8, 47.5) mL/m2, p=0.551) or ejection fraction (50.0% (41.0%-55.0%) vs 50.0% (43.0%-56.0%), p=0.554) was demonstrated. Similar results were observed with 90-day cardiovascular MRI. At 1 year, the clinical composite of death, congestive heart failure, cardiogenic shock and recurrent myocardial infarction was similar in RIC and SOC (21.7% vs 13.3%, p=0.110). CONCLUSIONS: In a contemporary registry-based randomised study of patients with STEMI undergoing PPCI, adjunctive therapy with RIC did not improve myocardial perfusion, reduce IS or alter LV performance. Consequently, there was no difference in clinical outcomes within 1 year. TRIAL REGISTRATION NUMBER: NCT03930589.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Bainey KR, Zheng Y, Coulden R, et al. Remote ischaemic conditioning in ST elevation myocardial infarction: a registry-based randomised trial. Heart. 2021. PMID: 34417205. doi:10.1136/heartjnl-2021-319455

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。